Literature DB >> 9328541

Why do women doctors in the UK take hormone replacement therapy?

A J Isaacs1, A R Britton, K McPherson.   

Abstract

STUDY
OBJECTIVES: To ascertain the determinants and experiences of hormone replacement therapy (HRT) use by menopausal women doctors.
DESIGN: Postal questionnaire.
SETTING: UK. PATIENTS: A randomized stratified sample of women doctors who obtained full registration between 1952 and 1976, taken from the current Principal List of the UK Medical Register. MAIN OUTCOME MEASURES: Current and previous use of HRT; reasons for and against HRT use; menopausal status; hormonal contraceptive use; lifestyle patterns; family and personal history of disease. MAIN
RESULTS: While 73.2% of 471 users had started HRT for symptom relief, 60.9% cited prevention of osteoporosis and 32.7 prevention of cardiovascular disease. Altogether 18.7% had started for preventive purposes alone. Significant predisposing factors to starting HRT were the presence and severity of menopausal symptoms, surgical menopause, past use of hormonal contraception, and a family history of osteoporosis. HRT users were also more likely to use skimmed rather than full fat milk, to try to increase their intake of fruit, vegetables, and fibre, and to undertake vigorous physical activity at least once a week. They were less likely to have had breast cancer. Long duration users were more likely than short duration users to be past users of hormonal contraception and to be using HRT for prevention of osteoporosis as well as symptom relief; they were less likely to have experienced side effects.
CONCLUSIONS: The high usage of HRT by women doctors reflects the fact that many started HRT on their own initiative and with long term prevention in mind. The results may become generalisable to the wider population as information on the potential benefits of HRT is disseminated and understood. However, HRT users may differ slightly from non-users in health-related behaviour and a substantial minority may never take up HRT, at least until the benefit-risk ratio is more clearly established.

Entities:  

Mesh:

Year:  1997        PMID: 9328541      PMCID: PMC1060503          DOI: 10.1136/jech.51.4.373

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  16 in total

Review 1.  Hormone replacement therapy and cardiovascular disease.

Authors:  T W Meade; A Berra
Journal:  Br Med Bull       Date:  1992-04       Impact factor: 4.291

2.  Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.

Authors:  M J Stampfer; G A Colditz
Journal:  Prev Med       Date:  1991-01       Impact factor: 4.018

3.  A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer.

Authors:  K K Steinberg; S B Thacker; S J Smith; D F Stroup; M M Zack; W D Flanders; R L Berkelman
Journal:  JAMA       Date:  1991-04-17       Impact factor: 56.272

4.  Premenopausal determinants of menopausal estrogen use.

Authors:  G M Egeland; L H Kuller; K A Matthews; S F Kelsey; J Cauley; D Guzick
Journal:  Prev Med       Date:  1991-05       Impact factor: 4.018

5.  Postmenopausal estrogen and prevention bias.

Authors:  E Barrett-Connor
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

6.  The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age.

Authors:  L Villard-Mackintosh; M P Vessey; L Jones
Journal:  Br J Obstet Gynaecol       Date:  1989-07

7.  Long-term estrogen replacement therapy prevents bone loss and fractures.

Authors:  B Ettinger; H K Genant; C E Cann
Journal:  Ann Intern Med       Date:  1985-03       Impact factor: 25.391

8.  Utilisation of hormone replacement therapy by women doctors.

Authors:  A J Isaacs; A R Britton; K McPherson
Journal:  BMJ       Date:  1995-11-25

9.  Hormone replacement therapy: a study of women's knowledge and attitudes.

Authors:  H K Sinclair; C M Bond; R J Taylor
Journal:  Br J Gen Pract       Date:  1993-09       Impact factor: 5.386

10.  Decreased mortality in users of estrogen replacement therapy.

Authors:  B E Henderson; A Paganini-Hill; R K Ross
Journal:  Arch Intern Med       Date:  1991-01
View more
  2 in total

1.  Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?

Authors:  Carey E Gleason; N Maritza Dowling; Elliot Friedman; Whitney Wharton; Sanjay Asthana
Journal:  Menopause       Date:  2012-05       Impact factor: 2.953

2.  Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.

Authors:  L J Lambert; J A Y Straton; M W Knuiman; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.